Effectiveness and Safety of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucleus
- Conditions
- Dislocated LensPars Plana VitrectomyPhacoemulsificationNeedle
- Registration Number
- NCT06709378
- Lead Sponsor
- Changzhou No.2 People's Hospital
- Brief Summary
The goal of this observational study is to learn about the effects of 25-gauge (G) needle-assisted phacoemulsification to remove dislocated intravitreal lens nuclei.
- Detailed Description
Patients with dislocated intravitreal lens nuclei who underwent 23G pars plana vitrectomy (PPV) and 25G needle-assisted phacoemulsification between July 2022 and September 2024 were included. Primary outcomes included best-corrected visual acuity (BCVA) and intraocular pressure (IOP). Secondary outcomes included corneal endothelial cell count (CECC) and the incidence of intraoperative and postoperative complications. These outcomes were statistically analyzed both preoperatively and postoperatively. A minimum follow-up of 6 months was completed for all eyes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 9
Clinical diagnosis of dislocated intravitreal lens nuclei Signed informed consent
Surgical contraindications
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best corrected visual acuity Preoperatively and postoperatively for at least 6 months. Best corrected visual acuity was measured with logarithmic visual acuity chart.
- Secondary Outcome Measures
Name Time Method Intraocular pressure Preoperatively and postoperatively for at least 6 months. Intraocular pressure was measured with noncontact tonometer.
Corneal endothelial cell count Preoperatively and postoperatively for at least 6 months. Corneal endothelial cell count was measured with specular microscope.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
the Second People's Hospital of Changzhou
🇨🇳Changzhou, Jiangsu, China